Date published: 2026-6-6

1-800-457-3801

SCBT Portrait Logo
Seach Input

Polr2j Activators

POLR2J Activators are a set of chemical compounds that indirectly enhance the functional activity of POLR2J, a subunit of RNA polymerase II, through various signaling pathways. Forskolin and Isoproterenol, by increasing intracellular cAMP levels, indirectly enhance POLR2J's role in mRNA synthesis through the activation of PKA, which phosphorylates transcription factors and components of the transcriptional machinery. Phorbol 12-myristate 13-acetate (PMA) activates PKC, leading to enhanced phosphorylation states of RNA polymerase II and its subunit POLR2J, thus improving transcription efficiency. Ionomycin and A23187 (Calcimycin), both acting as calcium ionophores, raise intracellular calcium levels and activate calcium-dependent kinases, which may increase the activity of POLR2J by phosphorylating transcription factors or coactivators working with RNA polymerase II. Sphingosine-1-phosphate engages G-protein coupled receptors to activate downstream kinases such as ERK and AKT, potentially leading to the phosphorylation of transcription factors that recruit POLR2J for gene transcription, thereby enhancing its function. Similarly, Epigallocatechin gallate (EGCG), by inhibiting various kinases, might reduce competitive phosphorylation, favoring transcription pathways that utilize POLR2J.

The activity of POLR2J is further influenced by compounds that modulate cellular signaling, creating an environment conducive to its function in transcription. Dibutyryl cyclic AMP (db-cAMP), a cell-permeable analog of cAMP, activates PKA and contributes to the enhanced activity of POLR2J through the phosphorylation of transcriptional regulatory proteins. PI3K inhibitors like LY294002 and Wortmannin may shift cellular signaling dynamics, indirectly affecting the transcription complex involving POLR2J and potentially enhancing its transcriptional activity. Staurosporine, though a broad-spectrum kinase inhibitor, could inhibit kinases that negatively regulate transcription factors or coactivators associated with POLR2J, thus potentially enhancing its transcriptional activity. Finally, Okadaic acid, by inhibiting protein phosphatases 1 and 2A, increases the phosphorylation levels of proteins within the cell, which may lead to an enhanced phosphorylation state of RNA polymerase II and POLR2J, improving POLR2J's role in transcription. These chemical activators collectively support the transcriptional activity of POLR2J without altering its expression levels, instead facilitating the function of POLR2J within the larger RNA polymerase II complex.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

PMA is an activator of protein kinase C (PKC) which can phosphorylate proteins involved in the regulation of transcription. PKC activation can lead to enhanced phosphorylation states of RNA polymerase II, including the POLR2J subunit, improving its transcriptional efficiency.

Ionomycin

56092-82-1sc-3592
sc-3592A
1 mg
5 mg
$78.00
$270.00
80
(4)

Ionomycin is a calcium ionophore that increases intracellular calcium levels. Elevated calcium can activate calcium-dependent protein kinases, which may phosphorylate transcription factors or coactivators working with RNA polymerase II, hence indirectly increasing POLR2J function in transcription.

D-erythro-Sphingosine-1-phosphate

26993-30-6sc-201383
sc-201383D
sc-201383A
sc-201383B
sc-201383C
1 mg
2 mg
5 mg
10 mg
25 mg
$165.00
$322.00
$570.00
$907.00
$1727.00
7
(1)

Sphingosine-1-phosphate acts through G-protein coupled receptors to activate downstream kinases such as ERK and AKT, which can lead to the phosphorylation of transcription factors that recruit POLR2J for gene transcription.

A23187

52665-69-7sc-3591
sc-3591B
sc-3591A
sc-3591C
1 mg
5 mg
10 mg
25 mg
$55.00
$131.00
$203.00
$317.00
23
(1)

A23187 is another calcium ionophore that raises intracellular calcium, similar to Ionomycin. This activation of calcium-dependent kinases could enhance the recruitment and activity of RNA polymerase II subunit POLR2J.

Isoproterenol Hydrochloride

51-30-9sc-202188
sc-202188A
100 mg
500 mg
$28.00
$38.00
5
(0)

Isoproterenol is a beta-adrenergic agonist that increases cAMP levels, thereby activating PKA. PKA may phosphorylate transcriptional machinery components, which could enhance POLR2J's role in transcriptional initiation and elongation.

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$43.00
$73.00
$126.00
$243.00
$530.00
$1259.00
11
(1)

EGCG is known to inhibit several kinases, potentially reducing competitive phosphorylation events and thus favoring pathways that lead to the activation of transcription factors that recruit POLR2J in RNA polymerase II-mediated transcription.

Dibutyryl-cAMP

16980-89-5sc-201567
sc-201567A
sc-201567B
sc-201567C
20 mg
100 mg
500 mg
10 g
$47.00
$136.00
$492.00
$4552.00
74
(7)

db-cAMP is a cell-permeable cAMP analog that activates PKA. PKA activation can result in enhanced POLR2J activity through phosphorylation of associated transcriptional regulatory proteins.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 is a PI3K inhibitor that may shift the balance of cellular signaling, indirectly affecting the transcription complex involving POLR2J, potentially enhancing its activity in the process of transcription.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Wortmannin is another PI3K inhibitor with a mechanism similar to LY294002, which could indirectly lead to the activation of transcriptional machinery by affecting signaling pathways that involve POLR2J.

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$153.00
$396.00
113
(4)

Staurosporine is a broad-spectrum kinase inhibitor that may inhibit kinases that negatively regulate transcription factors or coactivators of RNA polymerase II, thereby potentially enhancing the activity of POLR2J.